The effect of curcumin supplementation on pain caused by neuropathy in patients treated with taxanes
Phase 3
Recruiting
- Conditions
- Condition 1: Neuropathy caused by receiving taxanes. Condition 2: cancer.
- Registration Number
- IRCT20220802055602N1
- Lead Sponsor
- Kerman University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
Having symptoms of neuropathy
Confirmation of neuropathy by ncv test and doctor's examination
Exclusion Criteria
Cancer patients who have neuropathy caused by factors other than chemotherapy drugs, such as diabetics, pregnant and lactating mothers, people who receive painkillers such as morphine
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ??? ???????? (?? ???? ???? ??? ????????) ???????? ?? ????? ???? ?????? ???? ?????? ?? ?????? ??????. Timepoint: Evaluation of neuropathy in patients is before the administration of drugs, in the middle of the administration period (45 days after the administration of the interventions i.e. the administration of the first dose of drugs, placebo and positive control) and after the treatment (up to 1 month after the last administration of the interventions). Method of measurement: Nerve conduction speed test, doctor's examination and questionnaire.
- Secondary Outcome Measures
Name Time Method